Theravance Biopharma, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q1 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Theravance Biopharma, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2013 to Q3 2024.
  • Theravance Biopharma, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $2.65M, a 93.6% increase year-over-year.
  • Theravance Biopharma, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $8.71M.
  • Theravance Biopharma, Inc. annual Income Tax Expense (Benefit) for 2023 was $5.92M, a 65722% increase from 2022.
  • Theravance Biopharma, Inc. annual Income Tax Expense (Benefit) for 2022 was $9K.
  • Theravance Biopharma, Inc. annual Income Tax Expense (Benefit) for 2021 was -$151K, a 98.2% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $8.71M $2.65M +$1.28M +93.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $7.43M $1.31M -$150K -10.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $7.58M $1.26M +$1.66M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $5.92M $3.49M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-01
Q3 2023 $1.37M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $1.46M +$1.46M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$395K -$919K -175% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q2 2022 $361K -$5K +$215K +97.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $146K $524K +$297K +131% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$151K -$151K +$8.65M +98.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-01
Q3 2021 -$8.8M -$7K -$100K -108% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$8.7M -$220K -$259K -664% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$8.44M $227K +$80K +54.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 -$8.52M -$8.8M -$8.85M -18057% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $328K $93K +$5.65M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$5.32M $39K -$162K -80.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$5.16M $147K +$67K +83.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$5.22M $49K +$3.31M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 -$8.53M -$5.55M -$4.89M -742% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$3.63M $201K +$6.99M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$10.6M $80K -$64K -44.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 -$10.6M -$3.26M -$10.2M -147% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 -$316K -$659K -$1.53M -176% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $1.21M -$6.79M -$7.24M -1596% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-05
Q1 2018 $8.46M $144K -$5.24M -97.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $13.7M $6.99M -$1.58M -18.4% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 $15.3M $868K +$56K +6.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $15.2M $454K +$418K +1161% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 $14.8M $5.38M +$4.69M +676% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $10.1M $8.57M +$19.4M Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 -$9.29M $812K -$3.51M -81.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 -$5.78M $36K -$2.48M -98.6% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$3.3M $694K -$4.25M -86% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $951K -$10.8M -$10.4M -2255% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-28
Q3 2015 $11.3M $4.32M -$778K -15.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $12.1M $2.51M +$791K +45.9% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $11.3M $4.95M +$4.95M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $6.36M -$460K -$460K Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 $6.82M $5.1M +$5.1M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 $1.72M $1.72M +$1.72M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 $0 $0 $0 Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q4 2013 $0 $0 Oct 1, 2013 Dec 31, 2013 10-K 2016-03-11
Q3 2013 $0 Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 $0 Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 $0 Jan 1, 2013 Mar 31, 2013 10-Q 2014-06-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.